Banco Bilbao Vizcaya Argentaria’s Neurocrine Biosciences NBIX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,540	Closed	-$204K	–	756
2026 Q1	$204K	Sell	1,540 -147,616	-99%	-$19.6M	﹤0.01%	712
2025 Q4	$21.2M	Buy	149,156 +1,367	+0.9%	+$198K	0.15%	116
2025 Q3	$20.7M	Sell	147,789 -91	-0.1%	-$12.3K	0.16%	116
2025 Q2	$18.6M	Buy	147,880 +4,511	+3%	+$517K	0.17%	115
2025 Q1	$15.9M	Buy	143,369 +3,699	+3%	+$469K	0.16%	126
2024 Q4	$19.1M	Buy	139,670 +915	+0.7%	+$113K	0.2%	105
2024 Q3	$16M	Hold	138,755	–	–	0.16%	125
2024 Q2	$19.1M	Hold	138,755	–	–	0.2%	103
2024 Q1	$19.1M	Hold	138,755	–	–	0.22%	101
2023 Q4	$18.3M	Hold	138,755	–	–	0.22%	105
2023 Q3	$15.6M	Hold	138,755	–	–	0.21%	108
2023 Q2	$13.1M	Buy	138,755 +5,022	+4%	+$491K	0.17%	134
2023 Q1	$13.5M	Hold	133,733	–	–	0.17%	127
2022 Q4	$16M	Hold	133,733	–	–	0.23%	98
2022 Q3	$14.2M	Hold	133,733	–	–	0.23%	87
2022 Q2	$13M	Hold	133,733	–	–	0.2%	109
2022 Q1	$13.2M	Hold	133,733	–	–	0.18%	113
2021 Q4	$11.3M	Buy	+133,733	New	+$12.3M	0.15%	132
2020 Q3	–	Sell	-5,000	Closed	-$610K	–	731
2020 Q2	$610K	Hold	5,000	–	–	0.02%	514
2020 Q1	$432K	Buy	+5,000	New	+$489K	0.02%	515

Other funds holding NBIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's NBIX Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria sold out of Neurocrine Biosciences (NBIX) in Q2 2026, closing a stake of 1,540 shares — an estimated $204K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in NBIX in Q1 2020 and held it in 20 quarters. The position peaked at $21.2M in Q4 2025. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

Banco Bilbao Vizcaya Argentaria reported no remaining Neurocrine Biosciences position as of Q2 2026 after selling out during the quarter.
Banco Bilbao Vizcaya Argentaria sold 1,540 Neurocrine Biosciences shares in Q2 2026, an estimated $204K.
Banco Bilbao Vizcaya Argentaria first reported a position in Neurocrine Biosciences in Q1 2020 and held it in 20 quarters.
Banco Bilbao Vizcaya Argentaria's Neurocrine Biosciences position peaked at $21.2M in Q4 2025.
781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.